Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma
Status:
Completed
Trial end date:
2011-12-27
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety, tolerability, and pharmacokinetics (PK) of multiple dose
treatment with MK-1029 in adults with mild to moderate persistent asthma.